Autumn Ellis
@autumnellis.bsky.social
International Collaboration to Develop and Harmonize Drug Interaction Guidance for Nirmatrelvir/Ritonavir During COVID-19: Lessons Learned for Future Pandemic Preparedness
✅ Just Accepted
🔗 https://bit.ly/43TxFlJ
✅ Just Accepted
🔗 https://bit.ly/43TxFlJ
November 25, 2025 at 5:40 AM
Does oral antibiotic switching therapy show similar efficacy to intravenous administration for treating infective endocarditis?
✅ Just Accepted
🔗 https://bit.ly/3JNCW7x
✅ Just Accepted
🔗 https://bit.ly/3JNCW7x
November 25, 2025 at 5:40 AM
Nontuberculous mycobacterial disease, predominantly caused by Mycobacterium avium complex (MAC), is an emerging global health concern. In OFID, authors investigated mortality and causes of death among patients with MAC isolates. https://bit.ly/43fZlRD
Mortality and Causes of Death in Patients with Mycobacterium avium Complex Isolates through 28 years
This nationwide study of 2,027 Danish patients with MAC isolates (1991-2018) revealed declining mortality. Age, male sex, DMAC, and comorbidities were asso
academic.oup.com
November 25, 2025 at 5:37 AM
Triazoles versus Echinocandins for the first-line treatment of invasive pulmonary aspergillosis ? A propensity score weighted multicenter study
✅ Just Accepted
🔗 https://bit.ly/3LV7LYP
✅ Just Accepted
🔗 https://bit.ly/3LV7LYP
November 25, 2025 at 5:29 AM
A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein
#IDSky
#IDSky
A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in 2012 and has since spread worldwide
bit.ly
November 4, 2025 at 10:54 PM
Comparative Analysis of Flight Volume Effects on COVID-19 and Influenza Transmission Across Variable Control Intensities, 2019-2024
✅ Just Accepted
🔗 https://bit.ly/47FJT2v
✅ Just Accepted
🔗 https://bit.ly/47FJT2v
November 4, 2025 at 10:54 PM
Trial data show ensitrelvir has potent antiviral activity against COVID-19
Data from a phase 2 randomized controlled clinical trial show ensitrelvir accelerated viral clearance in patients with early symptomatic COVID-19.
www.cidrap.umn.edu/c...
Data from a phase 2 randomized controlled clinical trial show ensitrelvir accelerated viral clearance in patients with early symptomatic COVID-19.
www.cidrap.umn.edu/c...
November 4, 2025 at 10:51 PM
C-reactive protein in TB meningitis: a viable biomarker for individualized care.
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IXBkId
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IXBkId
November 4, 2025 at 10:50 PM
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Ws4x0Q
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Ws4x0Q
November 4, 2025 at 10:50 PM
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
#IDSky
#IDSky
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19
We report an interim analysis of safety and efficacy of pemivibart in individuals with (cohort A) or without (cohort B) significant immunocompromise in the phase 3 CANOPY trial.
bit.ly
November 4, 2025 at 10:50 PM
Impact of discontinuation of contact precautions on healthcare-associated ESBL-producing Escherichia coli in a large tertiary care hospital: an interrupted time-series analysis
✅ Just Accepted
🔗 https://bit.ly/47t7eEk
✅ Just Accepted
🔗 https://bit.ly/47t7eEk
November 4, 2025 at 10:49 PM
Long-Acting Cabotegravir/Rilpivirine for Treatment of HIV During Pregnancy: A Case Series
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hxXPjI
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hxXPjI
November 4, 2025 at 10:49 PM
Mortality and Causes of Death in Patients with Mycobacterium avium Complex Isolates through 28 years
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Mortality and Causes of Death in Patients with Mycobacterium avium Complex Isolates through 28 years
This nationwide study of 2,027 Danish patients with MAC isolates (1991-2018) revealed declining mortality. Age, male sex, DMAC, and comorbidities were asso
bit.ly
November 4, 2025 at 10:49 PM
Consequences of Delaying Surgical Intervention in Patients with Native Joint Septic Arthritis
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Consequences of Delaying Surgical Intervention in Patients with Native Joint Septic Arthritis
AbstractBackground. Although recent guidance recommends early surgical debridement for native joint septic arthritis (NJSA), supporting data, particularly
bit.ly
November 4, 2025 at 10:47 PM
Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4og9whx
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4og9whx
November 4, 2025 at 10:46 PM
Fitness of SARS-CoV-2 Omicron Subvariants in Respiratory and Gastrointestinal Cell Lines as Determined by Reverse-Transcription Droplet Digital PCR and Whole-Genome Sequencing
#IDSky
#IDSky
Fitness of SARS-CoV-2 Omicron Subvariants in Respiratory and Gastrointestinal Cell Lines as Determined by Reverse-Transcription Droplet Digital PCR and Whole-Genome Sequencing
The fitness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants was determined in human epithelial and continuous cells of the respiratory and gastrointestinal tracts
bit.ly
November 4, 2025 at 10:46 PM
The deadly Klebsiella pneumoniae can resist nearly all antibiotics. Colleagues found a new antibody that blocks its protective coat, helping the immune system clear the infection. This offers hope against the “silent pandemic” of #AMR.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae - Nature
Capsule-specific human monoclonal antibodies are protective against bloodstream infection by Klebsiella pneumoniae sequence type 147 in a mouse model of septicaemia, and could provide a useful strategy against pathogens with antimicrobial resistance.
www.nature.com
October 29, 2025 at 1:07 PM
WHO reports 1 in 6 bacterial infections worldwide are antibiotic-resistant, with resistance rising sharply since 2018. Gram-negative bacteria like E. coli and K. pneumoniae pose the biggest threat. Action on #AMR surveillance and responsible antibiotic use is needed.
www.who.int/news/item/13...
www.who.int/news/item/13...
WHO warns of widespread resistance to common antibiotics worldwide
One in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments, according to a new World Health Organization (WHO) r...
www.who.int
October 29, 2025 at 1:06 PM
Tuberculosis Preventive Treatment for Pregnant People With HIV in South Africa: A Modeling Analysis of Clinical Benefits and Risks
#IDSky
#IDSky
Tuberculosis Preventive Treatment for Pregnant People With HIV in South Africa: A Modeling Analysis of Clinical Benefits and Risks
Although prior studies of tuberculosis-preventive treatment (TPT) for pregnant people with human immunodeficiency virus (PPWH) report conflicting adverse pregnancy outcome (APO) risks, international guidelines recommend TPT for PPWH.
bit.ly
October 29, 2025 at 1:03 PM
Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosis
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47csDBA
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47csDBA
October 29, 2025 at 1:02 PM
Novel KPC-2 plasmid in a clinical Salmonella Rissen selected by antibiotic pressure
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hp4aOm
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hp4aOm
October 29, 2025 at 12:58 PM
Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4og9whx
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4og9whx
October 29, 2025 at 12:58 PM
C-reactive protein in TB meningitis: a viable biomarker for individualized care.
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IXBkId
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IXBkId
October 29, 2025 at 12:57 PM
Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial)
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial)
AbstractBackground. Delayed pulmonary tuberculosis (TB) diagnosis, especially with limited bronchoscopy resources, worsens outcomes and increases transmiss
bit.ly
October 29, 2025 at 12:55 PM